Faricimab for neovascular age-related macular degeneration and diabetic macular edema: from preclinical studies to phase 3 outcomes.
Agostini H, Abreu F, Baumal CR, Chang DS, G Csaky K, Demetriades AM, Kodjikian L, Lim JI, Margaron P, Monés JM, Peto T, Ricci F, Rüth M, Singh RP, Stoilov I, Swaminathan B, Willis JR, Westenskow PD.
Agostini H, et al. Among authors: singh rp.
Graefes Arch Clin Exp Ophthalmol. 2024 Jun 7. doi: 10.1007/s00417-024-06531-9. Online ahead of print.
Graefes Arch Clin Exp Ophthalmol. 2024.
PMID: 38847896
Review.